Related Experiment Video
Updated: May 14, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Practical guide to supportive care of patients with functional neuroendocrine tumors
1Department of Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA. Lowell.anthony@uky.edu
Abstract:
Supportive care of patients with functional neuroendocrine tumors (NETs) has evolved to include the use of multiple targeted agents to control paraneoplastic states and newer surgical and interventional radiologic techniques to reduce tumor bulk. Challenges encountered by the clinician are the recognition of specific symptom complexes, selecting the relevant laboratory tests and radiologic/scintigraphic scans, and the timing of intervention(s). Individual variables such as the severity of symptoms in the context of primary and metastatic disease sites, tumor bulk, comorbidities, and previous treatment are factors determining the prioritization of specific treatment regimens for patients with functional NETs. Symptoms such as flushing, secretory diarrhea, hypercalcemia, hyper /hypoglycemia, hypercortisolism, and peptic ulcers should improve with decreasing the elevated amino acid and/or peptide levels produced by NETs. These paraneoplastic symptoms may be accompanied by complaints related to tumor burden such as fatigue, pain, early satiety, anorexia, weight loss, night sweats, and/or symptoms secondary to adverse drug effects such as mucositis, dysgeusia, diarrhea, rash, hypertension, and myelosuppression. Developing a comprehensive continuum of care plan early in disease management assists in controlling the presenting signs and symptoms, and in minimizing disease- and/or treatment-related side effects. This guide serves as a framework to manage the signs and symptoms of metastatic functional neuroendocrine tumors.
Insights
Managing functional neuroendocrine tumors (NETs) involves targeted therapies and interventions to control symptoms and reduce tumor burden. Early, comprehensive care plans are crucial for optimizing patient outcomes and minimizing side effects.
Area of Science:
- Oncology
- Endocrinology
- Gastroenterology
Background:
- Supportive care for functional neuroendocrine tumors (NETs) has advanced with targeted agents and improved surgical/radiologic techniques.
- Clinicians face challenges in recognizing symptom complexes, selecting diagnostic tests, and timing interventions for NETs.
- Patient-specific factors like symptom severity, disease site, tumor bulk, comorbidities, and prior treatments influence management strategies.
Purpose of the Study:
- To provide a framework for managing signs and symptoms in patients with metastatic functional neuroendocrine tumors.
- To guide clinicians in recognizing and addressing paraneoplastic syndromes and tumor burden-related complaints.
- To emphasize the importance of a comprehensive continuum of care in NET management.
Main Methods:
- Review of current supportive care strategies for functional neuroendocrine tumors.
- Integration of targeted therapies, surgical, and interventional radiologic techniques.
- Consideration of individual patient variables for treatment prioritization.
Main Results:
- Effective management of functional NETs requires addressing both paraneoplastic symptoms (e.g., flushing, diarrhea) and tumor burden symptoms (e.g., fatigue, pain).
- Symptom improvement is linked to reducing elevated amino acid and peptide levels produced by NETs.
- Minimizing treatment-related side effects (e.g., mucositis, myelosuppression) is a key component of supportive care.
Conclusions:
- A comprehensive, early-stage care plan is essential for controlling presenting signs and symptoms in functional NETs.
- Proactive management can significantly minimize disease- and treatment-related side effects.
- This guide offers a framework for optimizing supportive care in metastatic functional neuroendocrine tumors.
Related Concept Videos
Treatment Resistant Cancers
Cushing Syndrome I: Introduction
Kidney Transplant III: Nursing Management
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...